31686034|t|Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
31686034|a|We identified a PSEN1 (presenilin 1) mutation carrier from the world's largest autosomal dominant Alzheimer's disease kindred, who did not develop mild cognitive impairment until her seventies, three decades after the expected age of clinical onset. The individual had two copies of the APOE3 Christchurch (R136S) mutation, unusually high brain amyloid levels and limited tau and neurodegenerative measurements. Our findings have implications for the role of APOE in the pathogenesis, treatment and prevention of Alzheimer's disease.
31686034	24	32	dominant	Disease	MESH:C566739
31686034	33	52	Alzheimer's disease	Disease	MESH:D000544
31686034	59	64	APOE3	Gene	348
31686034	121	126	PSEN1	Gene	5663
31686034	128	140	presenilin 1	Gene	5663
31686034	194	202	dominant	Disease	MESH:C566739
31686034	203	222	Alzheimer's disease	Disease	MESH:D000544
31686034	257	277	cognitive impairment	Disease	MESH:D003072
31686034	392	397	APOE3	Gene	348
31686034	412	417	R136S	ProteinMutation	tmVar:p|SUB|R|136|S;HGVS:p.R136S;VariantGroup:0;CorrespondingGene:348;CorrespondingSpecies:9606
31686034	477	480	tau	Gene	4137
31686034	564	568	APOE	Gene	348
31686034	618	637	Alzheimer's disease	Disease	MESH:D000544
31686034	Association	MESH:D000544	348
31686034	Association	MESH:D000544	5663
31686034	Association	MESH:D000544	HGVS:p.R136S;CorrespondingGene:348
31686034	Association	MESH:C566739	348
31686034	Association	MESH:C566739	5663
31686034	Association	MESH:D000544	348

